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Intracellular transport, cell-surface exposure and release of recombi-
nant Tamm-Horsfall glycoprotein. Human Tamm-Horsfall glycoprotein
(T-H), first described as the major urinary glycoprotein, is a glycosyiphos-
phatidyl-inositol (GPI)-anchored membrane protein which mainly resides
at the luminal face of cells of the thick ascending limb of Henle's loop
(TAL) and early distal convoluted tubules of nephron. Since no human
renal cell-line producing T-H is available, T-H eDNA was transfected in
UcLa cells and a cell line was selected in which 95% of the cells stably
expressed T-H, in order to elucidate the biosynthesis, mechanisms regu-
lating the transport of T-H along the exocytie pathway, exposure at the cell
surface and release in soluble form. Treatment of cells with an exogenous
reducing agent results in a drastic delay in the conversion from precursor
to mature T-H. Since the accumulating T-H-preeursor carries glycans not
yet processed by Golgi-mannosidases, we propose that the formation of a
correct set of intrachain disulphide bonds is required for T-H exit out the
endoplasmic reticulum. Even the treatment of cells with an inhibitor of
GPI-anchor biosynthesis results in an intracellular accumulation of T-H
precursor, loss of T-H localization into Golgi apparatus and reduced
surface exposure. These results indicate that the GPI-anchor addition is
necessary for T-H delivery to the cell-surface. The release rate of new
synthesized T-H shows an initial lag time very likely depending on the time
required for T-H surface exposure. A portion of released T-H appears to
contain ethanolamine, a component of GPI anchor, indicating that, at
least in HeLa cells, a GPI-specific phospholipase contributes to the T-H
release. Exposure of cells to monensin and brefeldin A results in a loss of
accumulation of T-H in the Golgi perinuclear region and a reduced
delivery to the cell surface. Under monensin treatment an intermediate
T-H form non-exposed at the cell surface is released in the medium,
indicating that a soluble T-H may be produced inside the cell under
conditions that alter the Golgi apparatus. If such an event occurs in
polarized kidney cells, a T-H release from the basolateral face may be
postulated, inasmuch as the GPI-anchor is an apical sorting signal. Since
T-H is a powerful autoantigen, the accumulation of soluble T-H in the
interstitium of TAL may cause the formation of immunocomplexcs.
Human Tamm-Horsfall glycoprotcin (T-H) has been first de-
scribed as an urinary glycoprotcin [1]. Indeed, T-H is the most
abundant protein in normal human urine, being excreted in
quantities of 50 to 100 mg per 24 hours [2]. In urine it occurs in
form of large aggregates (Mr 6 x 106) constituted by a single
glycoprotein of 80 kDa in unreduced sodiumdodecylsulphate-
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polyaciylamide gel electrophoresis (SDS-PAGE), which contains
about 30% carbohydrate [reviewed in 3]. The peptide moiety of
T-H, deduced by eDNA sequence, comprises 616 amino acids and
8 potential N-glyeosylation sites [4, 5]. When RNAs isolated from
about 150 different cell tissues were hybridized with a large probe
for T-H RNA, only RNA from human adult kidney gives a
positive signal, indicating that T-H is exclusively produced by
kidney cells [4]. Immunoelectron microscopy has shown that T-H
resides irs the thick ascending limb of Henle's loop (TAL) and in
the early distal convoluted tubules of nephron [6—8]. Rindler et a!
[9] demonstrated that T-H is a glycosylphosphatidylinositol
(GPI)-anchored membrane protein and the addition of the GPI-
anchor is very likely responsible for the delivery of the protein to
the apical face of renal cells. On this basis, it may be assumed that
urinary T-H is the released counterpart of membrane-bound
protein. Indeed, many GPI-anchored proteins have been found in
body fluids as soluble forms, very likely produced by the action of
GPI-specific phospholipases or proteases [10]. Ours and other
studies [11—14] on the carbohydrate structure of urinary T-H
demonstrated that it contains exclusively N-linked glycans, mainly
of polyantennary type largely sialylated and fucosylated, but
high-mannose glycans (Man57GlcNAc2) have been consistently
found in T-H isolated from pooled urine of various individuals
[15—17].
We have previously studied [18] the biosynthesis and oligosac-
charide processing of T-H permanently expressed by HeLa cells
and have demonstrated that an 84 kDa precursor form is slowly
converted into the mature glycoprotcin with an apparent molec-
ular weight of 97 kDa (SDS-PAGE in reducing conditions) very
similar to that of T-H purified from human urine. The mass
increase is due to the processing of the majority of high-mannose
glycans to complex type glycans. The low maturation rate was
suggested to he dependent on a lengthy retention of the precursor
in the endoplasmic reticulum (ER). Owing to the high cysteine
content of T-H, we postulated [18] that the rate limiting step for
its export out ER compartment is the formation of a correct set of
disulphide bonds that are in large part catalyzed by ER protein
disulphide isomerase.
The physiological function of T-H glycoprotein has not been
clarified to date. Speculations has been advanced mainly related
to properties and structural features of urinary T-H. For instance,
since the urinary T-H has a high gel-forming tendency [19, 20], it
has been postulated that it takes part in the water impermeability
of TAL [7, 21]. It is also been proposed that T-H plays a protective
role towards pyelonephritogenic pathogens, such as Escherichia
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coli strains, which mediate the adhesion to the host cells by
adhesins recognizing carbohydrate sequences of T-H, such as
high-mannose glycans [18, 221. T-H may inhibit the colonization
of these pathogens in the renal mucosa in that the soluble form
competes with that exposed at the plasma membrane.
Taking into accounts all these observations, it is important to
ascertain mechanisms regulating the transport of T-H along the
exocytic pathway, exposure at the cell surface and release as
soluble protein. We investigated three steps of such a process: (i)
the rate of exit from the endoplasmic reticulum (ER), very likely
related to the formation of a correct set of disulphide bonds and
incorporation of GPI-anchor; (ii) the role of N-glycan processing,
occurring in the Golgi apparatus, in the delivery of T-H to the cell
surface; (iii) the efficiency of release in soluble form. Since no
human renal cell-line producing T-H is available, the investigation
has been performed using transfected HeLa cells, which perma-
nently express T-H [181.
METHODS
Materials
Urinary T-H was prepared as previously described [20]. Anti-
serum to T-H was raised in rabbits as described by Bloomfield et
al [23j. High-mannose glycopeptides and endo-f3-N-acetylglu-
cosaminidase H (Endo-H) released oligosaccharides were pre-
pared from urinary T-H as previously described [16]. [35S]methi-
onine (specific activity > 1000 mCi/mmol) was from ICN Flow
(USA), [3H]mannose (specific activity 25 mCi/mmol) was from
Du Pont (New England Nuclear, Boston, MA, USA), and
[3H]ethanolamine (specific activity 17.9 Ci/mmol) from Amer-
sham (Buckingham, UK). All culture reagents were supplied by
Gibco (Grand Island, NY, USA). Solid chemicals and liquid
reagents were obtained from E. Merck (Darmstadt, Germany)
and Farmitalia Carlo Erba (Milan, Italy). Coneanavalin A
(ConA)-Sepharose was from Pharmacia (Uppsala, Sweden). Bio-
Gel P-4 was from Bio-Rad (USA). Endo-H was from Seikagaku
Kogyo Co. Ltd. (Tokyo, Japan). Protein A-Sepharose, man-
nosamine (2-amino-2-deoxy D-mannose), monensin, brefeldin A
(BFA), weat germ agglutinin (WGA) and 13-octylglucoside were
from Sigma Chemical Company (Munich, Germany).
Cell culture
HeLa cells were stably transfected with eDNA encoding for
T-H as previously described [18j. From the transfected HeLa cells
a cell line (HeLaA3+) was selected by limit dilution; in HeLaA3+
95% of the cells stably expressed T-H, as quantitated by the
cytofluorimetric analysis, using anti-T-H antiserum followed by
fluorescein-conjugated anti-rabbit IgG. Cells were cultured in
DMEM with 5% fetal calf serum and 0.2 mg/ml G418.
Radioactive labeling
The labeling experiments were performed in cells at the con-
fluence. When [35S]methionine was used as radioactive precursor,
one hour before labeling the normal medium was replaced with
DMEM containing 5% fetal calf serum but lacking methionine
(labeling medium), and cells were then labeled for 15 to 60
minutes with labeling medium containing 100 .tCi/ml [35S]methi-
onine. Cells were chased for variable times with a medium
containing a tenfold excess of cold methionine and 10 j.g!ml of
cycloheximide (chase medium). When [3H]mannose was used as a
radioactive precursor the concentration of glucose in the labeling
medium was lowered to 0.1 g/liter. The [3H]mannose was at 100
.tCi/ml and had been evaporated in order to not change the
medium composition and salt concentration. After a 20-hour
labeling period the cells were chased three hours in a medium
with the usual concentration of glucose and in the presence of
cycloeximide (10 rgIml). [3H]ethanolamine (50 Ci/ml) in serum
free medium was added to the HeLaA3 + cell-monolayer and the
metabolic labeling period was for 30 hours.
Isolation of radiolabeled Tamm-Horsfall glycoprotein
At the end of labeling period the medium was collected, the cell
layer was washed with 20 m sodium phosphate buffer, pH 7.4,
containing 0.14 M NaCI (PBS), and then lysated by PBS containing
1% NP-40, 1% deoxycholate, 0.2 ms TPCK and 0.2 m TLCK
(buffer A). The radioactive T-H from both cell extracts and media
was immunoprecipitated by anti-TH rabbit antiserum adding 5 pJ
and 10 pA of antiserum to 100 jil of cell extract and to 1 ml of
centrifuged medium, respectively. The (T-H) antibodies complex
was incubated overnight at 4°C, then protein A Sepharose was
added and incubated for 90 minutes. The protein A Sepharose
was washed several times with buffer A, re-suspended in the buffer
used for the electrophoresis containing 1% SDS. Samples were
boiled for three minutes and subjected to SDS-PAGE (polyacryl-
amide, 8.5%). To immunoprecipitate T-H on the plasma mem-
brane, the antibody was loaded on the HeLaA3+ monolayer and
left at 4°C for 45 minutes. The antibody was then removed, and
the monolayer washed several times with PBS. Finally the mono-
layer was lysed and coupled to protein A-Sepharose as described
above.
Pronase digestion of [3H] mannose labeled Tamm-Horsfall and
fractionation of glycopeptides and oligosaccharides
The polyacrylamide gels were fluorographed to locate precur-
sor and mature T-H. The areas of interest in the gel were excised,
cut in small portions and subjected to Pronase digestion as
previously described [18]. At the end of the digestion 1 ml of water
was added, the mixture boiled for 10 minutes and centrifuged. The
pellet was suspended in 1 ml of water and re-treated as above. The
two supernatants were put together and lyophilized. In this way
about 90% of the radioactivity present in the gel was recovered.
Glycopeptides were fractionated on a column (1 x 75 cm) of
Bio-Gel P-4 (400 mesh) equilibrated in 0.1 M pyridine/acetate
buffer, pH 5 and on a column of ConA-Sepharose (0.5 X 10 cm)
as previously described [24]. Recovery of radioactivity after
chromatography on either column was 85 to 90%. The glycopep-
tides fractionated on Bio-Gel P-4 column as high-mannose species
were subjected to Endo-H and isolated from the reaction mixture
by Bio-Gel P-4 filtration. The radioactive oligomannosides ob-
tained by Endo-H treatment were analyzed by HPLC as previ-
ously described [18].
Analysis of Tamm-Horsfall release
HeLaA3 + cells monolayer (3 cm 0) were labeled for 30 hours
with [35S]methionine (50 tCi/ml) or [3H]ethanolamine (50 JLCi/
ml), and at the end of the labeling period the medium was
collected (30 hr labeling-medium). A new medium (serum free)
was added to the cell monolayer and after 24 hours (24 hr
--
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— -— — — — S — —
1342 Malagolini et al: Recombinant Tamm-Horsfall glycoprotein
Chase time hours 1
2-mercaptoethanol — +
medium) was collected and the cells harvested. T-H was immu-
noprecipitated from cell-lysate and the two media as described
above and subjected to SDS-PAGE and fluorography. The bands
of gel corresponding to mature T-H from cell lysate and media
were excised. Since [3Hjethanolamine-labeled T-H from the two
media was not visualized by fluorography (Fig. 3B), the portions
of gels parallel to that of mature T-H from cell-lysate were excised
from the corresponding lanes. The gel slides were subjected to
Pronase digestion as described above. The Pronase-digest was
separated by centrifugation, and the residual gel slides were
treated with H202 (5 hr at 50°C) and then eluted overnight with
Soluene (Packard). Pronase-digest and Soluene-eluted samples
were counted for radioactivity in n-scintillation counter.
Dot-blotting and immunodetection of Tamm-Horsfall
glycoprotein
Conditioned medium (serum free) was collected at the indi-
cated times and corresponding cell monolayers were washed three
times with PBS. Cells were lysated with PBS buffer, pH 7.4,
containing 60 mi octylglucoside and 5 mrvi EDTA. Serial dilutions
of lysate and medium were performed with the same buffer
containing 15 mt octylgiucoside. One hundred microliter aliquots
of dilutions were applied to the Hybond ECL membrane by a
dot-blotting commercial apparatus, then the membrane was incu-
bated with anti-T-H antiserum followed by anti-rabbit IgG con-
jugated to horseradish peroxidase and developed with the ECL
detection system (Amersham) as recommended by the supplier.
M
P
Fig. 1. Effect of 2-mercaptoethanol addition in
the medium of transfected HeLa cells on
Tamm-Horsfall glycoprotein (T-H) maturation.
Cells were pulsed for 15 minutes with
[35S]methionine and chased for increasing
periods. When present, 7 mt mercaptoethanol
was added to the chase medium. T-H was
immunoprecipitated from cell lysates and
subjected to SDS-PAGE analysis as described
in the text. M and P indicate the mature and
precursor form of T-H, respectively.
Immunofluorescence microscopy
Cells grown on glass coverslips were fixed in 2% paraformal-
dehyde and 0.1% glutaraldehyde in PBS for one hour at 0°C
(unpermeabilized cells) or with methanol pre-cooled at —20°C for
10 minutes (permeabilized cells). Unpermeabilized and perme-
abilized cells were incubated with pre-immune rabbit serum for 30
minutes at room temperature and then stained with anti-T-H
antiserum (1:1000 dilution) followed by fluorescein-conjugated
anti-rabbit IgG (1:300 dilution). Cells permeabilized and treated
with pre-immune rabbit serum as described above were incubated
for 30 minutes with WGA (10 j.g/ml) and then with fluorescein-
conjugated anti-WGA rabbit-antibodies (Sigma).
RESULTS
Maturation rate of Tamm-Horsfall glycoprotein in the presence
of 2-mercaptoethanol
There is evidence that the addition of exogenous reducing
agents, such as 2-mercaptoethanol and dithiothreitol (DYT), to
the medium of living cells prevents the disulphide formation in
newly synthesized proteins [25, 26]. To investigate the relevance of
disulphide formation in the rate of T-H maturation, transfected
HeLa cells were pulsed for 15 minutes with [35S]methionine, and
chased for increasing times in the presence or absence of 7 mM
2-mercaptoethanol. Figure 1 shows that at all chase times the ratio
between precursor and mature T-H was in favor of the former
when mercaptoethanol was present in the chase medium, indicat-
ing that the kinetics of maturation was decreased under the action
2 4 8
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Fig. 2. Characterization of [3Hlmannose-
labeled glycans of mature forms of T-H and of
the precursor accumulating in 2-
% mercaptoethanol-treated cells. Cells were
continuously labeled for 20 hours with
[3H]mannose in the absence or presence of 7
mM 2-mercaptoethanol. Fluorography of SDS-
PAGE is shown in the insert. The portions of
12 gel corresponding to the bands of mature T-H
58 (M) and of precursor (P) were excised and
30 subjected to Pronase-digestion. Glycopeptides
and oligosaccharides were fractionated as
described in the Methods section. The values
are the percentage of the [3H]mannose-derived
radioactivity recovered in each type of
glycopeptides or oligosaccharides. Data are the
means of two different experiments.
of the reducing agent. No significant change was observed in the
apparent molecular weight of mature protein synthesized by
untreated and treated cells, suggesting that in the latter conditions
the portion of glycoprotein that undergoes to maturation is
efficiently processed by Golgi glycosyltransferases. To ascertain
this point, untreated and 2-mercaptoethanol-treated cells were
labeled with [3Hjmannose for 24 hours and the two mature T-Hs
as well as the precursor accumulated in treated cells were isolated
by immunoprecipitation and SDS-PAGE. Pronase glycopeptides
from mature T-Hs were fractionated by ConA-Sepharose in order
to ascertain the glycan-processing pattern [27] while pronase
glycopeptides from precursor were digested by Endo-H and the
reduced glycans analyzed by I-IPLC. A very similar ConA-Sepha-
rose chromatographic profile of glycopeptides from the two T-H
mature forms was observed. In both cases the majority of glyco-
peptides was eluted as polyantennary glycans (unretained by
ConA-Sepharose column) and as diantennaiy glycans (eluted by 5
mM a-methylmannose; Fig. 2). On the contrary, all glycopeptides
from T-H precursor accumulated in mercaptoethanol-treated
cells strongly bound to ConA-Sepharose (eluted by 300 mrvi
a-methylmannose) and after Endo-H treatment and HPLC anal-
ysis were eluted as Man89GlcNAc, which are considered glycans
not yet trimmed by Golgi mannosidases [28J. These results
indicate that an exogenous reducing agent strongly delays the T-H
exit out of the endoplasmic reticulum very likely because it
interferes with the formation of disulphide bounds which are
essential for a correct folding of the protein. 2-Mercaptoethanol
does not affect significantly the subsequent glycans processing
occurring into the Golgi apparatus.
Release of newly synthesized Tamm-Horsfall glycoprotein
HeLaA3 + cells were pulsed for one hour with [35S]methionine,
chased for increasing times and, at the end of each chase time
lysates and media were immunoprecipitated and subjected to
SDS-PAGE analysis. After a chase of eight hours, when the
conversion from the precursor to the mature form was completed,
the T-H was detectable in the medium and its release increased
with the chase period (Fig. 3A). The initial lag time in the release
very likely corresponded to the period required for the transit
along the exocytic pathway and exposure of mature glycoprotein
at the plasma membrane.
To investigate how membrane-bound T-H is released, particu-
larly if proteases or a GPI-specific phospholipase were responsible
for the cleavage, HeLaA3+ cells were metabolically labeled (30
hr) with [3H]ethanolamine, a component of GPI-anchor (Fig. 4).
Fluorography of SDS-PAGE visualized [3H]ethanolamine-labeled
T-H from cell lysate, but not from the conditioned medium
collected at the end of the labeling period and 24 hours later (Fig.
3B). On the contrary, when cells were similarly labeled with
[35Sjmethionine, and the medium collected at the same times, the
fluorograpy of SDS-PAGE clearly visualized the [35S]methionine-
labeled T-H released in the medium (Fig. 3B). Since [3Hllabeled-
proteins are more hardly detectable by fluorography than [35S]-
labeled proteins, these results did not prove that the released T-H
was devoid of ethanolamine. To clarify this point, the gel slides
corresponding to various T-Hs separated by SDS-PAGE as shown
in Figure 3B were analyzed by n-scintillation counting. As de-
tailed in the Methods section, radioactive T-Hs were removed
from the gel slides first by pronase treatment, which usually results
in the solubilization of 90 to 95% of peptide components [18], and
then by Soluene. Considering that there are 15 methionine
residues versus 1 ethanolamine per T-H mole, the much higher
radioactivity recovered in [35S]methionine-labeled T-H samples
was expected. As shown in Table 1, the percentage of labeled T-H
released from cell-bound [3H]ethanolamine-labeled T-H was sig-
nificantly lower than that released from cell-bound [35S}methi-
onine-labeled T-H. The data of Table 1 have allowed us to
calculate that 15 to 30% of the total T-H released contains
[31-l]ethanolamine, indicating that a GPI-specific phospholipase
contributes to the T-H cleavage.
Relative proportion of cell-bound and released T-H
The total amount of T-H released by HeLaA3+ cells in the
medium relative to that cell-bound was determined by the ECL
dot-blot immunodetection. A preparation of urinary T-H purified
to homogeneity was used as standard [20]. Figure 5 shows a
representative dot-blotting experiment of T-H recovered in cell
lysates and media collected at increasing times of culture. As
expected, a time-dependent release of T-H was found. The ratio
between the T-H amount quantitated in 24-hour conditioned
medium and that in corresponding cell lysate was 0.18 (mean of 2
different experiments), a value close to that found for T-H release
from [35Slmethionine-labeled T-H (Table 1). When lysates and
conditioned media of untransfected HeLa were analyzed with this
procedure no positive signal could be detected (results not
shown).
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A
Cell lysate Released in medium
Chase hours 1 2 4 8 16 24 1 2 4 8 16 24
M
P
B
[ ] l l l l  1
Cell 30 hr 24 hr Cell 30 hr 24 hr
lysate medium medium lysate medium medium
Fig. 3. Release of newly synthesized T-H. (A) HeLaA3+ cells were pulsed for one hour with [35S]methionine and chased for increasing periods as
indicated. T-H was immunoprecipitated from cell lysatcs and media and then subjected to SDS-PAGE. (B) HeLaA3+ cells were labeled with
[35S]methionine ([35SjMet) or [3Hlethanolamine ([3HIEthN) for 30 hours and T-H was immunoprecipitated from cell lysates and the two conditioned
media collected either at the end of labeling period (30 hr medium) or at further 24 hours (24 hr medium) and then subjected to SDS-PAGE as
described in the text. Fluorography of gel corresponding to [3H]ethanolamine ([3H]EthN)-laheled T-H was exposed for seven weeks.
Effect of mannosamine on the maturation and release of T-H Protein
glycoprotein
A bulk of evidence indicates that GPI-anchor attachment ---— Protease
occurs at the luminal side of endoplasmic reticulum compartment
[29]. This reaction is a transamidase type of process where the Ethanolamine
original hydrophobic stretch of C-terminal amino acids is cleaved
and replaced by a preformed GPI-anchor via the terminal amino p
function of ethanolamine of GPI unit [10]. The more conserved
glycan structure of GPI anchor comprises the Manal,2Mannl, Manu 1,2-Man(x 1,66Manal ,4GIcN-R sequence (Fig. 4), and it has been observed that
when cells were treated with mannosamine there is a dramatic Mana 1,4-GlcN
impairment of the GPI-anchor biosynthesis and a reduced expo-
sure of GPI-anchored glycoproteins at the cell-surface [30—32].
lnositolWe examined the effect of mannosamine-treatment on the
biosynthesis, surface exposure and release of T-H. When He- I
LaA3+ cells were pulsed for one hour with [35Sjmethionine and I GPI-PLD
chased for 20 hours in the presence of mannosamine, SDS-PAGE
analysis of the immunoprecipitate from cell lysate revealed a large P
accumulation of the precursor, and a medial mobility of mature I
T-H slightly faster than that produced by untreated cells (Fig. 6). Lipid
The accumulation of T-H precursor could be related to the
inefficient routing of T-H to the Golgi apparatus because of the Fig. 4. Minimal structure of a GPI-anchor. Abbreviations are: P, phos-phodiester group; Man, mannose; G1cN, glucosamine; GPI-PLD, GPI-inhibited biosynthesis of GPI-anchor [33], while the lower appar- specific phospholipase D. Arrows indicate the site of protease and
ent molecular weight of mature T-H is very likely dependent on GPI-PLD action.
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Table 1. Release analysis of [3H]ethanolamine (EtN)- or [35Sjmethionine (Met)-metabolically-labeled T-H
Tamm-Horsfallgiycoprotein (mature form) Pronase digest Soluene eluted Total
% of
Cell lysate
[3HIEtN-T-H from cell-lysate 1093 3414 4507 —
[3H]EtN-T-H from 30 hr labeling-medium 82 72 154 3.4
[3HJEtN-T-H from 24 hr medium
[3S]Met-T-H from lysate
[35S]Met-T-H from 30 hr labeling medium
52
30420
3560
44
2003
255
96
32423
3815
2.1
—
11.7
[35SlMet-T-H from 24 hr medium 4410 296 4706 14.5
The conditions of labeling and the /3-scintillation counting of T-H samples, separated by SDS-PAGE as shown in Fig. 3B, are as described in the text.
The values are means of two separate experiments.
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1/400
1/800
1/1600
1/3200
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1/10
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the altered N-glycosylation also produced by mannosamine treat-
ment [34]. Both in untreated and mannosamine-treated condi-
tions, only mature T-H appeared to be exposed at the cell surface
and released in the medium (Fig. 6). The amount and apparent
molecular weight of both cell-surface and released T-H were
similarly reduced under mannosamine treatment, strongly sug-
gesting that the cleavage producing the soluble form is an event
Medium
6hr l2hr 24hr T-H ng
10
5
2.5
1.25
0.625
occurring at the cell surface. Even in experiments in which the
treatment with mannosamine was extended to 24 hours, we did
not observed any degraded T-H-products either in cell lysates or
in the medium. Immunofluorescence microscopy of unpermeabi-
lized cells confirmed that mannosamine treatment drastically
reduced T-H localization at the cell-surface (Fig. 7 A, B). In
control permeabilized cells either WGA or anti-T-H antibodies
Fig. 5. Dot-blotting and ECL.immunodetection of T-H in cell lysate and medium of HeLaA3+ cells. Serial dilutions of lysate and medium were
performed as described in the text and 100 jrl of each dilution were applied to the Hybond ECL membrane. The membrane was incubated with anti-T-H
antiserum followed by horseradish peroxidase anti-rabbit IgG and developed with the ECL detection system.
ManN 0 10mM 0 10mM 0 10mM
Fig. 6. Effect of mannosamine (manN) on the
maturation, cell exposure and release of T-H.
HeLaA3+ cells were labeled for one hour with
M [35S]methionine and chased for 20 hours. When
present, mannosamine (10 mM) was added to
the medium three hours before the labeling
period and it was present during the pulse and
chase time. T-H was immunoprecipitated and
isolated from the cell lysate, cell-surface and
medium as described in the text. M and P
Cell lysate Cell surface Released indicate the mobility of mature and precursor
in medium T-H.
—IL JL1te
Icont.I [ManN
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Fig. 7. Immunofluorescence localization of T-H in mannosamine-treated or untreated HeLaA3+ cells. The cells were grown in coverslips and treated
or not with 10 m'i mannosamine for 20 hours. Then the cells were fixed in 2% paraformaldehyde and 0.1% glutaraldehyde in PBS for one hour at 0°C
(A and B: unpermeabilized cells) or with methanol for 10 minutes (C, D, and E: permeabilized cells). Unpermeabilized and permeabilized cells were
incubated with pre-immune rabbit serum for 30 minutes at room temperature and then stained with anti-T-H antiserum (A, B, D and E) or WGA (C)
followed by fluorescinated specific antibodies as described in the text.
illuminated the perinuclear structures (Fig. 7 C, D). Since WGA
is a lectin that detects fully processed glycoproteins and glycolip-
ids in that binds terminal sialic acid of glycans, it is a good marker
of Golgi structures [35]. Under mannosamine treatment, the
perinuclear localization of T-H was lost and an intense staining of
the reticular network of endoplasmic reticulum became apparent
(Fig. 7E), indicating that mannosamine treatment does inhibit the
exit out ER of T-H and its routing to the Golgi compartment.
Effect of monensin and brefeldin A on the release of Tamm-
Horsfall glycoprotein
Monensin is a monovalent carboxylic ionophore that largely
affects the function of Golgi compartment and inhibits the
processing of N-glycans from high mannose to the polyantennaiy
type [36]. We investigated the effect of monensin on the matura-
tion and release of T-H to ascertain the relevance of full process-
ing of N-glycans in facilitating the T-H transport and exposure at
the cell surface. As expected, under monensin treatment the
maturation of T-H was radically altered: T-H from cell-lysate
migrated as a broad band with a medial mobility much faster than
that of T-H produced by untreated cells (Fig. 8). At the cell-
surface only a narrow band was visualized with a mobility corre-
sponding to the upper portion of the band visualized in the cell
lysate, but faster than that exposed to the surface of mannosamine
treated cells. Remarkably, under monensin treatment a T-H
intermediate migrating with a mobility close to that of the T-H
precursor was visualized in the medium (Fig. 8). The latter result
was unexpected because only the mature T-H form had been
consistently found in the cells medium, and this indicates that a
soluble T-H may be produced before the glycoprotein is fully
processed by Golgi glycosyltransferases and delivered to the
plasma membrane. It is worth noting that the soluble form
although appeared to have a mobility very close to that of T-H
precursor did not appear to be degraded.
Treatment of cells with brefeldin A (BFA) has been demon-
strated to induce a rapid redistribution of Golgi proteins into the
endoplasmic reticulum (ER) compartment and a consequent
impairment of the glycosylation mediated by distal compartments
of Golgi apparatus [37]. As expected, BFA-treated cells accumu-
lated a T-H form with a faster mobility of fully processed mature
T-H, in the medium such a form was practically absent, while a
faint smear of degraded products was visualized (Fig. 8), suggest-
ing that intracellular T-H is degraded when Golgi apparatus fuses
with the ER. In agreement with the inefficient maturation process
of T-H indicated by SDS-PAGE analysis, the immunofluores-
cence microscopy of monensin- and BFA-treated cells showed a
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Fig. 8. Effect of monensin and brefeldin on the maturation, cell exposure and release of T-H. HeLaA3+ cells were pulsed for one hour with
[35S]methionine and chased for four hours. Monensin (10 /LM) or BFA (10 j.g/ml) were added to the medium at the chase time. The procedure of T-H
isolation was as indicated in the legend of Figure 6.
Fig. 9. Immunofluorescence localization of T-H upon monensin and BFA cell treatment. Monensin (10 M) or BFA (10 jrglml) were added to the cell
medium and left for two hours. After washing, cells were fixed with methanol (permeabilized cells) and T-H was localized as described in the legend
of Figure 7.
strongly reduced perinuclear staining and dispersal of T-H
throughout the cell cytoplasm (Fig. 9).
DISCUSSION
There are several demonstrations that a correct folding is
necessary for the export out the endoplasmic reticulum (ER) of
both soluble and membrane-hound glycoproteins [reviewed in 381.
In the case of glycoproteins containing disulphide bonds the
formation of a correct set of disulphides is thought to occur in ER
because it provides a sufficiently oxidizing environment and there
is a high content of protein disulphide isomerase. T-H contains 48
cysteinc residues/mol prevalently distributed in the N-terminal
portion of the peptide (37 residues in the first 295 aa). No free
suiphydryl groups have been detected in T-H and all cysteine
residues have been proposed to be involved in intrachain disul-
phide bonds [39]. Indeed, the mobility of T-H in SDS-PAGE in
reducing conditions does not appear to be faster than that
ohserved in unreducing conditions. In fact, in unreducing condi-
tions the apparent molecular weight of T-H, either the urinary or
mature membrane-bound form manufactured by HeLaA3+ cells,
decreases from 96 to 80 kDa. Such a decrement is very likely
dependent on the large degree of polypeptide constrains imposed
by intrachain disulphide bonds [40]. For some proteins the folding
and oligomcrization occur cotranslationally and in few minutes
the protein is exported out of the ER, but for other proteins the
half time of permanence in the ER is of several hours [411. The
differences in the folding rate have been related to the nature of
polypeptide backbone rather than to the expression level [42].
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Previously we observed that the biosynthesis of T-H permanently
expressed by HeLa cells was characterized by a low conversion
rate from the precursor to mature form and proposed that the rate
limiting step was the formation of a very high number of disul-
phide bridges required for a correct folding and for the exit out
the ER [18]. Current results showing a drastically delay in the
conversion of the precursor into mature T-H in cells exposed to
2-mercaptoethanol indicate that the formation of disulphide
bonds regulates the efficiency of T-H maturation. Since the glycan
structure of the precursor accumulating in mercaptoethanol
treated cells carries exclusively Man89GlcNAc2 sequences, one
may infer that the precursor is a T-I-l intermediate still residing in
the ER [28]. We did not observed the complete arrest of T-H into
the ER as it has been observed for some proteins synthesized by
cells exposed to DTT [25], probably because 2-mercaptoethanol is
a milder reducing agent than the former. Interestingly, the portion
of T-H that exits out of the ER in mercaptoethanol-treated cells
appears to be processed by Golgi glycosyltransferases, indicating
that at least the glycosylation function of the Golgi apparatus is
poorly affected by exogenous reducing agents.
Several conditions interfering with the GPI attachment process,
such as those preventing the cleavage of the C-terminus signal or
the biosynthesis of GPI-anchor, were found to inhibit the delivery
of GPI-anchored proteins to the cell surface [30, 33, 43]. By using
mannosamine as an inhibitor of GPI biosynthesis we found that
the addition of GPI-anchor is also required for T-H delivery to the
cell surface. In contrast to a previous result [44], no degradation
of intracellularly accumulated T-H was observed in man-
nosamine-treated HeLaA3+ cells, suggesting that such an event is
protein- and cell-dependent. In untreated cells, intracellular T-H
appears to be mainly located in the Golgi apparatus. When
[3Hlmannose-labeled glycopeptides isolated from intracellular
mature T-H were fractionated on DEAE-Sephacel chromatogra-
phy they were entirely separated as di- and trisialylated glycopep-
tides (results not shown). Altogether these observations support
the notion that mature T-H accumulates in the distal compart-
ments of Golgi apparatus before being exposed at the cell surface.
Various signal functions have been assigned to the UPI-anchor,
including the facts that GPI-anchored proteins associate with
Golgi glycosphingolipids to form microdomains in the trans-Golgi
network and that this association facilitates the sorting of GPI-
proteins to the apical cell surface [45]. Recently [46], GPI-
anchored proteins have been described to cluster in plasma
membrane conformations known as caveolae, and it has been
proposed that the clustering of GPI-proteins with specific ligands
in caveolae may be a crucial event in promoting specific functions
at the cell surface.
Interestingly, T-H from rat shows 53% identity and 86%
similarity with rat GP-2 the major glycoprotein of zymogen
granule membranes of the exocrine pancreas [471. GP-2 is also a
GPI-anchored proteins and, similarly to urinary T-H, the GP-2
soluble form from the pancreatic juice shows ion-dependence and
pH-induced self-association [47]. Leblond et al [481 showed that
zymogen aggregation is strongly affected by the presence of GP-2
even in an acidic environment similar to that believed to exist in
trans-Golgi network and proposed that the co-aggregation of the
GP-2 and zymogen facilitates the routing of latter towards the
regulated secretory pathway. One may ask if T-H accumulated in
the distal compartments of the Golgi apparatus has a function of
carrier of molecules that must be sorted to the apical face of renal
cells in which T-H accumulates. To answer to this question an
investigation must be done in kidney cells producing T-H. It is
worth noting that a study on the ultrastructural localization of
T-H in rat kidney showed the presence of clear vesicles positive
for T-H in close spatial relationship to the Golgi stacks and in
fusion with the apical face of the thick ascending limb of Henle's
loop [49].
The release of T-H from transfected HeLa cells very likely
occurs by a cleavage of that exposed at the cell surface. The
mechanism(s) by which GPI-anchored proteins are released from
the cell surface is still poorly understood. In eucaryotic cells both
proteases and/or GPI-specific phospholipases may be involved in
the cleavage. There is evidence that human serum contains a
phospholipase D able to cleave GPI-anchored proteins [50], and
recently in HeLa cells a cell-associated GPI-specific phospho-
lipase D has been reported by Metz et al [51]. These authors
observed that the decay accelerating factor, which is also a
GPI-anchored protein, is secreted by [3H]ethanolamine- and
[3H]inositol-labeled HeLa cells and contains both radiolabeled
components. They calculated that about 40% of the molecules are
released via phospholipase D. When we performed a similar
experiment with [3H]ethanolamine as the labeled precursor, a
lower percentage of [3Hlethanolamine-labeled T-H was found in
the medium relative to the total T-H released. The scarce
accessibility of membrane-bound T-H to the cell-associated GPI-
specific phospholipase D may explain our result. On the other
hand, these observations cannot be extended to explain the
manner in which T-H is released in urine by kidney cells of TAL,
in that the occurrence and the level of a GPI-specific phospho-
lipase D in renal cells producing T-H have not been investigated.
The cloning of T-H cDNA in kidney cells, such as MDCK, could
be a good model to face the problem.
Current results show also that, when functions of Golgi appa-
ratus are altered by monensin, a cleavage of T-H may occur before
the delivery of the glycoprotein to the cell surface. This result may
be relevant in understanding the role of T-H in some pathological
conditions of kidney. T-H is a powerful autoantigen [52], but in
physiological conditions the exclusive release from the apical face
of tubular renal cells very likely prevents the immunological
response to T-H. In humans, T-H deposits in the interstitium of
TAL have been demonstrated to accompany tubulointerstitial
diseases [53] and antibodies to T-H have been observed in the
serum of patients with pyelonephritis and reflux nephropathies
[54, 551 Recently [56, 57], a proinflammatory potential of T-H has
been proposed in that it triggers some neutrophil functions.
Various kinds of cell damage may result in the accumulation of
T-H in the interstitium, such as necrosis of TAL cells or loss of
their apical/basolateral polarization. Since the GPI-anchor is
thought to be the sorting signal to the apical membrane, even the
cleavage of the GPI-anchor before T-H delivery to the cell surface
may be a way by which T-H is excreted by the basolateral face.
Therefore, the accumulation of soluble T-H in the interstitium of
TAL, which causes the formation of immunocomplexes and
inflammatory process, may also occur via perturbation of Golgi
apparatus functions.
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APPENDIX
Abbreviations are: T-H, Tamm-Horsfall glycoprotein; GPI, glyco-
sylphosphatidyl-inositol; TAL, thick ascending limb of Henle's loop; ER,
endoplasmic reticulum; BFA, brefeldin A; ManN, mannosamine.
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